Director/PDMR Shareholding

RNS Number : 1743T
Kromek Group PLC
10 October 2017
 

10 October 2017

 

Kromek Group plc

("Kromek" or the "Company" or the "Group")

 

Director/PDMR Shareholdings

 

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has received notification of the following purchases by Directors of Ordinary Shares of 1 pence each ("Ordinary Shares") in the Company:

 

Director

Position

Date of transaction

Number of Ordinary Shares purchased in the transaction

Price at which Ordinary Shares were purchased

Number of Ordinary Shares held post transaction

Percentage of share capital held post transaction








Derek Bulmer

Chief Financial Officer

9 October 2017

36,066

24.4p

100,000

0.04%








Lawrence Kinet

Non-executive Director

4 October 2017

50,000

23.5p

250,000

0.10%

 

 

 

 

Enquiries:

 

Kromek Group plc

+44 (0)1740 626 060

Arnab Basu, CEO

Derek Bulmer, CFO

 

 

 

Cenkos Securities plc

+44 (0)20 7397 8900

Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

 

 

 

Luther Pendragon Ltd

+44 (0)20 7618 9100

Harry Chathli, Claire Norbury, Alexis Gore

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Derek Bulmer

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

GB00BD7V5D43

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

24.4p

 

36,066

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

36,066 Ordinary Shares

 

 

24.4p per Ordinary Share

 

e)

 

Date of the transaction

 

 

9 October 2017

 

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Lawrence Kinet

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

GB00BD7V5D43

 

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

23.5p

 

50,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

50,000 Ordinary Shares

 

 

23.5p per Ordinary Share

 

e)

 

Date of the transaction

 

 

4 October 2017

 

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

About Kromek Group plc

 

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

                                                                                   

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKKDQFBDKPKD

Companies

Kromek Group (KMK)
UK 100

Latest directors dealings